Innovation and regulation in human implant technologies: developing comparative approaches.

Area of Science:

• Medical Technology
• Health Policy
• Sociology of Health

Background:

• Human implant technologies are rapidly advancing, creating challenges in testing, clinical performance, risk assessment, and regulation.
• The European Union's harmonization of medical device standards significantly impacts the regulatory landscape.
• Existing research often examines implant technologies in isolation, lacking comparative analysis.

Purpose of the Study:

• To compare the historical development and current regulatory environments of breast implants and artificial hips.
• To identify key differences influencing innovation, clinical evidence, and public perception.
• To propose a sociological healthcare research agenda for evaluating implant technologies.

Main Methods:

• Comparative historical analysis of breast implants and artificial hips, focusing on the UK.
• Examination of institutional contexts, clinician-manufacturer alliances, public controversy, and adverse incident definitions.
• Review of national vigilance systems and data registers.

Main Results:

• Significant contrasts exist in how clinical evidence is presented, the role of industry partnerships, and the level of public concern.
• Definitions of 'adverse incidents' and the presence of national registries (e.g., for breast implants but not hip implants in the UK) vary.
• International differences in these aspects were also observed.

Conclusions:

• Improved understanding of institutional, organizational, and professional processes in implant innovation and regulation is crucial.
• A comparative research agenda focusing on innovativeness, safety, outcomes, and consumer information is proposed.
• Such research will strengthen the evidence base for evaluating human implant technologies within their regulatory contexts.